Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	9,474	7,320	13,192	10,163	-	-
Market Cap Growth	0.80%	-44.51%	29.81%	-	-	-
Enterprise Value	9,589	7,469	13,164	10,212	-	-
Last Close Price	820.50	626.84	1116.16	859.02	-	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	23.80	19.79	45.38	49.53	-	-
PS Ratio	0.90	0.86	2.13	4.77	-	-
PB Ratio	1.68	1.89	4.67	5.80	-	-
P/TBV Ratio	1.84	2.14	5.34	6.83	-	-
P/FCF Ratio	401.19	203.90	439.73	-	-	-
P/OCF Ratio	60.51	40.31	189.00	752.80	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.92	0.88	2.12	4.80	-	-
EV/EBITDA Ratio	16.24	13.34	28.75	35.56	-	-
EV/EBIT Ratio	16.89	13.85	29.52	36.68	-	-
EV/FCF Ratio	405.94	208.04	438.80	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.04	0.07	0.08	0.08	0.42	0.03
Debt / EBITDA Ratio	0.42	0.48	0.49	0.49	0.71	0.04
Debt / FCF Ratio	10.57	7.54	7.66	-	3.08	0.04
Net Debt / Equity Ratio	-0.05	-0.07	-0.01	-0.06	0.26	-0.14
Net Debt / EBITDA Ratio	-0.50	-0.50	-0.09	-0.37	0.44	-0.22
Net Debt / FCF Ratio	-12.40	-7.75	-1.43	5.53	1.90	-0.19
Asset Turnover	1.58	1.69	1.62	1.16	1.79	1.84
Inventory Turnover	10.52	12.01	11.26	7.53	22.88	8.96
Quick Ratio	1.33	1.31	1.11	0.99	0.97	0.44
Current Ratio	2.14	1.98	1.82	1.51	1.39	0.84
Return on Equity (ROE)	10.76%	13.78%	16.79%	24.98%	66.14%	71.37%
Return on Assets (ROA)	5.34%	6.67%	7.28%	9.46%	26.40%	19.63%
Return on Invested Capital (ROIC)	8.27%	13.19%	16.35%	23.77%	53.60%	77.53%
Return on Capital Employed (ROCE)	8.90%	12.60%	14.30%	14.50%	40.30%	63.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.20%	5.05%	2.20%	2.02%	-	-
FCF Yield	0.25%	0.49%	0.23%	-0.19%	-	-
Dividend Yield	0.12%	0.16%	0.13%	0.09%	-	-
Payout Ratio	3.01%	3.19%	4.06%	2.88%	-	-
Buyback Yield / Dilution	0.27%	-100.00%	47.86%	-38.35%	-2.10%	-
Total Shareholder Return	0.39%	-99.84%	47.99%	-38.27%	-2.10%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 11, 2026

Data Sources Report a data error